CAR-T Therapy in India: A New Hope for Cancer
CAR-T cell therapy is a breakthrough cancer treatment that uses a patient’s own immune cells, re-engineered in a lab, to target and destroy cancer cells. It offers new hope for patients with advanced or treatment-resistant blood cancers.
Medico Solutions connects you with India’s leading CAR-T experts, ensuring access to world-class treatment, advanced labs, and personalized care.
Our Expertise Areas
Acute Lymphoblastic Leukemia (ALL)
Effective therapy for relapsed or refractory ALL patients.
Diffuse Large B-Cell Lymphoma (DLBCL)
Advanced treatment for aggressive forms of non-Hodgkin lymphoma.
Multiple Myeloma (Select Cases)
Promising option for patients with resistant or recurrent myeloma.
Pediatric Leukemia (B-ALL)
Specialized care for children diagnosed with B-cell acute lymphoblastic leukemia.
Personalized Immunotherapy
Tailored CAR-T treatment designed to match each patient’s condition.
Access to Cutting-Edge Research Trials
Opportunities for eligible patients to join global CAR-T clinical studies.